LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. (LMAT) Revenue
Annual & quarterly revenue history · segment & region breakdown
LMAT · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsLeMaitre Vascular, Inc. trailing twelve-month (TTM) revenue is $0.26B, an increase of 13.53% year-over-year from $0.25B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.25B | +$0.03B | +13.53% |
| 2024-12-31 | $0.22B | +$0.03B | +13.63% |
| 2023-12-31 | $0.19B | +$0.03B | +19.69% |
| 2022-12-31 | $0.16B | +$0.01B | +4.68% |
| 2021-12-31 | $0.15B | +$0.03B | +19.37% |
| 2020-12-31 | $0.13B | +$0.01B | +10.35% |
| 2019-12-31 | $0.12B | +$0.01B | +11.05% |
| 2018-12-31 | $0.11B | +$0.00B | +4.66% |
| 2017-12-31 | $0.10B | +$0.01B | +13.14% |
| 2016-12-31 | $0.09B | +$0.01B | +13.78% |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare LMAT revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income LeMaitre Vascular, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
LeMaitre Vascular, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from LeMaitre Vascular, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LMAT revenue · 4 questionsLMAT's trailing twelve-month (TTM) revenue is $0.26B. That is an increase of 13.53% year-over-year from $0.25B in FY2025.
▸ Source: FMP · LeMaitre Vascular, Inc. SEC filings · GAAP · LeMaitre Vascular, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026